<?xml version="1.0" encoding="UTF-8"?>
<p>Nevertheless, the current evidence does not provide a definitive answer regarding whether ACEIs/ARBs should be continued or withheld in the perioperative setting. While some studies showed that continuation of ACEIs/ARBs was associated with an increased risk of intraoperative hypotension (
 <xref rid="B11" ref-type="bibr">11</xref>–
 <xref rid="B15" ref-type="bibr">15</xref>), other studies argued that different ACEIs/ARBs management strategies did not affect perioperative hemodynamic stability or postoperative outcomes (
 <xref rid="B16" ref-type="bibr">16</xref>–
 <xref rid="B19" ref-type="bibr">19</xref>). To date, there is no well-designed randomized controlled trial with adequate power to assess the perioperative risks and benefits of ACEIs/ARBs.
</p>
